PGNX
Tudor Investment Corp’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-31,817
| Closed | -$189K | – | 1344 |
|
|
2017
Q4 | $189K | Buy |
+31,817
| New | +$189K | ﹤0.01% | 963 |
|
|
2017
Q2 | – | Sell |
-10,100
| Closed | -$95K | – | 1501 |
|
|
2017
Q1 | $95K | Buy |
10,100
+5,900
| +140% | +$55.5K | ﹤0.01% | 1306 |
|
|
2016
Q4 | $36K | Sell |
4,200
-283,613
| -99% | -$2.43M | ﹤0.01% | 1322 |
|
|
2016
Q3 | $1.82M | Sell |
287,813
-2,054,575
| -88% | -$13M | 0.04% | 219 |
|
|
2016
Q2 | $9.89M | Sell |
2,342,388
-22,100
| -0.9% | -$93.3K | 0.21% | 50 |
|
|
2016
Q1 | $10.3M | Sell |
2,364,488
-6,272
| -0.3% | -$27.3K | 0.26% | 55 |
|
|
2015
Q4 | $14.5M | Sell |
2,370,760
-21,339
| -0.9% | -$131K | 0.41% | 39 |
|
|
2015
Q3 | $13.7M | Buy |
2,392,099
+4,391
| +0.2% | +$25.1K | 0.46% | 28 |
|
|
2015
Q2 | $17.8M | Buy |
2,387,708
+45,320
| +2% | +$338K | 0.52% | 33 |
|
|
2015
Q1 | $14M | Sell |
2,342,388
-28,115
| -1% | -$168K | 0.45% | 32 |
|
|
2014
Q4 | $17.9M | Buy |
2,370,503
+14,411
| +0.6% | +$109K | 0.62% | 9 |
|
|
2014
Q3 | $12.2M | Buy |
2,356,092
+13,704
| +0.6% | +$71.1K | 0.44% | 28 |
|
|
2014
Q2 | $10.1M | Hold |
2,342,388
| – | – | 0.39% | 45 |
|
|
2014
Q1 | $9.58M | Sell |
2,342,388
-407
| -0% | -$1.67K | 0.41% | 55 |
|
|
2013
Q4 | $12.5M | Buy |
2,342,795
+407
| +0% | +$2.17K | 0.61% | 28 |
|
|
2013
Q3 | $11.8M | Hold |
2,342,388
| – | – | 0.48% | 30 |
|
|
2013
Q2 | $10.4M | Buy |
+2,342,388
| New | +$10.4M | 0.78% | 28 |
|